The influence of norepinephrine on the diameter of single pial arteries and arterioles was investigated by adding the drug to the perivascular space with micropipettes. The mock spinal fluid solution in which the norepinephrine was dissolved contained 0, 11, or 22 mEq/liter of bicarbonate. These concentrations of bicarbonate were by themselves found to dilate, cause no change, and constrict the pial vessels, respectively. Concentration-response curves with 11 mEq/liter of bicarbonate over the concentration range of 5 X 1O"* to 5 mmoles/liter of norepinephrine showed significant constriction at 5 X 10~2 mmoles/liter and maximal constriction (40% of diameter) at 2.5 mmoles/liter. In bicarbonate-free solution, the slope of the concentration-response curves was less, and at 22 mEq/liter of bicarbonate norepinephrine had no effect. The pial arteries seemed to be less sensitive than the mesenteric and the cremasteric arteries to norepinephrine. The present data demonstrate the existence of norepinephrine receptors on the pial arterial smooth muscle cells, which satisfies the major requirement for the possible existence of a sympathetic control of cerebral blood flow.
• The influence of intravascular injections of norepinephrine (1) (2) (3) (4) (5) (6) and the effects of cervical sympathetic nerve stimulation (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) have been frequently studied. The results, however, have not yet yielded a clear picture of the role of catecholamines in the control of cerebral blood flow.
Several authors (1-3) have observed a decrease in cerebral blood flow following intravenous infusion of norepinephrine. However, this decrease might not be caused by the vasoconstrictor action of the infused norepinephrine on the cerebral vessels, but rather it might be due to the concomitant decrease in arterial CO 2 content during the course of norepinephrine infusion. According to the data of Reivich (18) and Olesen (19) , these changes in cerebral blood flow can be quantitatively explained by the changes in arterial CO 2 during the infusion.
Experiments in which cerebral blood flow was measured either by the inert gas clearance technique (6) or by using an electromagnetic flowmeter (5) demonstrated that no change in cerebral blood flow occurred on infusion of norepinephrine into the internal carotid artery. On the other hand, it is well established that sympathetic nerves make contact with the cerebral vessels (20) (21) (22) (23) (24) (25) (26) (27) . The results of several groups of investigators, who stimulated the cervical sympathetic chain or ganglia and observed a decrease in cerebral blood flow or constriction of pial arteries, or both, argue in favor of sympathetic control of the cerebral vessels (7, 10, (13) (14) (15) (16) .
The discrepancy between the results obtained by intracarotid application of norepinephrine and those obtained by sympathetic 249 nerve stimulation might be explained by the fact that the concentration of norepinephrine at the smooth muscle receptor site which can be attained by intracarotid infusion may be considerably lower than that achieved by sympathetic nerve discharge. The application of norepinephrine at the perivascular site of the vessel allows the use of high concentrations. Reports of previous studies in which catecholamines were applied to the pial surface of the vessels have not supplied sufficient data about the bicarbonate content of the solvent fluid (28) (29) (30) . A recent microapplication study (31) has shown that this factor is of decisive importance in determining the arterial diameter. This technique has the advantage that the fluid can be injected directly into the perivascular space so that a possible arachnoid barrier is eliminated. The very local application ensures that vasomotor reactions are due to primary effects on the vessel's wall and not to secondary changes in neuronal function and metabolism.
The present study was undertaken to test whether the pial arteries are sensitive to perivascular application of norepinephrine and to determine if an effect induced by norepinephrine can be influenced by alterations in the perivascular bicarbonate concentration.
Methods
Experiments were performed on 15 cats of either sex, anesthetized by intravenous injection of 40-50 ing/kg of glucochloralose and allowed to breathe spontaneously. The Pco 2 , pH, and Po 2 of the arterial blood were measured in some of the experiments with Astrup equipment. pH was 7.31 ± 0 . 0 6 (SD), PCO 2 was 32.7 ± 3.7 (SD) mm Hg, and Po. was 90.1 ± 6 . 3 (SD) mm Hg. The value of arterial Pco 2 is similar to values obtained in conscious cats (32, 33) . The pH, when compared to that in conscious-cats (7.45 and 7.38), is somewhat low; this finding might be explained by a slight metabolic acidosis resulting from anesthesia. In the other experiments the end-tidal CO 2 was monitored by an infrared gas analyzer and was 4.17 ± 0.60* (SD) of the total volume. The arterial blood pressure was recorded continuously by a strain gauge and a Hellige recorder. Cats with a mean arterial blood pressure of less than 100 mm Hg were not used. Body Circulation Rn**rcb, Vol. XXXI, Amgust 1972 temperature was maintained at 37-38° C. To counteract fluid loss an infusion of Tyrode's solution (2.5 ml/kg hour" 1 ) was given intravenously. Parts of the parietal and temporal lobe of the brain were exposed by craniotomy (opening in the skull was 1.5 X 3 cm), and the dura was removed. Great care was taken to carry out this operation as gently as possible without touching the brain. The brain surface was bathed by mineral oil heated to 37-38°C. Using a Bausch and Lomb Stereo-Zoom microscope at a magnification of 40x, the cortical surface was observed and photographed with a Nikkor camera. The magnification remained unchanged during the experiment. Ilford FP4 black-and-white film was used. Glass micropipettes with sharpened tips o.d.) were filled with test solutions and sealed between oil to reduce CO 2 diffusion from the test solution. The filled micropipette was mounted on a micromanipulator and the tip was positioned in the immediate vicinity of a superficial artery or arteriole. In general, we examined vessels surrounded only by a fine layer of arachnoidal tissue and not those embedded in the cerebral surface, thus excluding the possibility of neuronal damage. In the few cases in which vessels embedded in the cerebral surface were examined, the results were the same and no distinction has been made between the two groups. By applying pressure to a syringe attached to the micropipette, 1-3 yu.liters of fluid was injected into the perivascular space. The pial vessels were photographed before and 20 and 40 seconds after the beginning of the injection of the test solution. The diameter of the vessels was measured from magnified photographic prints using a caliper. Sample photographs have been published in a previous paper (31) . The prints allowed precise definition of the point of transition from the black, which reflected the vessel, to the light background. Since we were not able to decide whether this point of transition reflected the position of the outermost or the innermost layer of the vessel or perhaps an intermediate zone, we preferred to use the term "vascular diameter" only. For the question posed in this paper, a differentiation between outer and inner diameter was not critical as long as the measured diameters referred to identical vascular layers.
The reproducibility of the method was assessed from repeated measurements of the diameter of the same vessel. For vessels with diameters ranging from 25 to 208/x, the standard deviation was ±1.5^, in 50 measurements and it was independent of diameter. The same standard deviation was found when a series of photographs was taken from the same vessel. This practically excluded the possibility that respiratory movements of the brain influenced the measured diameters.
Before applying Z-norepinephrine, mock spinal fluid solution containing bicarbonate concentrations of 5, 11, or 22 mEq/liter but no norepinephrine was added to the perivascular space of the vessel-Only those vessels which responded typically with constriction at 22 mEq/liter of bicarbonate and dilation at 5 mEq/liter (34) were used for the application of norepinephrine. The norepinephrine was dissolved in mock spinal fluid solutions containing 0, 11, or 22 mEq/Iiter of bicarbonate. Concentrationresponse curves were obtained for norepinephrine from single vessels by serial tests with increasing concentrations of 5 X 1(H, 5 X 10" 3 , 5 X 10-2 , 5 X ICh 1 , 2.5 and 5.0 mmoles/liter at the same site on each vessel. The time between two injections was less than 1 minute. The mock spinal fluid was prepared fresh daily from two stock solutions containing Na + , K + , Ca 2 + , and Clĩ n various concentrations. Both were equilibrated with 5% CO 2 , sodium bicarbonate (420 mg/100 ml) was added to one of them, and the solutions were then covered with mineral oil. Different amounts of both solutions were mixed to produce solutions with different bicarbonate and Crconcentrations and constant cation concentration. The final solution had an osmolarity of 280 mosmoles/ liter and a cation composition of Na + 144 mEq/liter, K+ 5 mEq/liter, and Ca 2+ 5 mEq/liter. The anion composition was variable, since the bicarbonate concentration (0, 5, 11, or 22 mEq/liter) determined the Ch concentration (155, 150, 144, or 133 mEq/liter). The pH (38°C) at 0 mEq/liter of bicarbonate was 4.8, at 5 mEq/liter it was 6.80, at 11 mEq/liter 7.15, and at 22 mEq/liter 7.45. In all the test solutions the total CO 2 content was measured by a Natelson-Mikro-Van Slyke apparatus, and the bicarbonate concentration was calculated. The pH of all test solutions 1 was measured using a glass electrode and a Knick pH-meter. The Na + and K + concentrations of all solutions were determined using a Zeiss flamephotometer. Pure substance of Z-norepinephrine was dissolved in O.OIN HC1 and added to the bicarbonate-free stock solution to obtain the required norepinephrine concentrations. The pH was measured before and after the addition of norepinephrine. If the pH had changed, it was titrated back to the original value before norepinephrine was added. Then the two stock solutions were mixed. The pH and bicarbonate concentration of this artificial cerebrospinal fluid (CSF) were found to be the same as they were in the mock spinal fluid containing no norepinephrine.
The observed percent changes in vessel diameters were statistically evaluated by a twofactor analysis of variance (35) (factors: cats and concentrations). The effect of the control solution and of 5 X 1(H, 5 X KH, 5 X 10" 2 , and 5 X 10-1 mmoles/liter of norepinephrine were tested. For analysis of variance the following data were used: (1) mean value of two measurements taken at the test vessel 20 and 40 seconds after the beginning of injection of the test solution and (2) a second mean value determined at the same times but taken from a different vessel. Due to experimental difficulties in obtaining all the required measurements for the two-factor analysis of variance, analysis was performed using the data from five cats which were selected at random. The values shown in Figures 2, 3, and 4 are mean values of all measurements. Another kind of analysis of variance (factors: cats, concentrations, and replicates of concentrationresponse curves) was performed to test if a repetitive performance of concentration-response curves altered the vascular response. Figure 1 demonstrates that the cerebral vessels, when exposed to mock spinal fluid with different pH values, exhibit an unchanged reaction over 8 minutes, the time necessary to obtain concentration-response (36) . Since the local pH and bicarbonate concentration at the vessel wall have not yet been evaluated, it cannot be decided whether 11 mEq/liter of bicarbonate represents the actual bicarbonate concentration at the vessel wall.
Results

BICARBONATE
NOREPINEPHRINE
The microapplication of norepinephrine dissolved in mock spinal fluid (11 mEq/liter of bicarbonate) to the outside of pial arterial vessels was followed by a decrease in vessel diameter. The reduction in diameter was restricted to the site of microinjection. No alterations in blood pressure and end-tidal CO 2 were detected during the injection period.
As shown in Figure 2 , the concentrationresponse curves demonstrated a concentration- dependent vasoconstriction. The analysis of variance showed significant concentration effects (P<0.01). The maximal decrease in vessel diameter was 40% at a concentration of 2.5 mmoles/liter of norepinephrine. The lowest concentration of norepinephrine at which a decrease in vessel diameter could be statistically verified by the Tukey method (35) was 5 X 10~2 mmoles/liter. The pattern obtained from the analysis of all pooled data was also found to be the typical reaction of single vessels to which norepinephrine was applied in increasing concentrations from 5 X 10~* to 5.0 mmoles/liter. The solutions containing 11 mEq/liter of bicarbonate, although in the mean without effect when no norepinephrine was included ( Fig. 1) , might have had a slight effect on a given pial artery. To assess this, the effect of 11 mEq/liter of bicarbonate without norepinephrine was tested on each single vessel and subtracted from the observed response with norepinephrine. The calculated concentrationresponse curve for norepinephrine alone is indicated in Figure 2 by the broken line. This unspecific effect of the mock spinal fluid accounted for a mean reduction in vessel diameter of 2.1%.
The effect of norepinephrine on cerebral vessel diameter was independent of initial vessel size. This is demonstrated in Figure 3 . When vessels of diameters ranging from 30 to 220/A were exposed to norepinephrine (5 X 1O~2 and 5 X 10" 1 mmoles/liter), the percent reduction in diameter did not correlate with vessel Correlation between the initial vascular diameter and its percent change after application of 5 x 10-* and 5 X 10-1 . mmoles/liter of norepinephrine.
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size. Therefore, all changes in vessel diameter were expressed as percent of control, and the analysis of variance was performed using the percent values.
NOREPINEPHRINE AT DIFFERENT BICARBONATE CONCENTRATIONS
Concentration-response curves for norepinephrine at solvent bicarbonate concentrations of 0, 11, or 22 mEq/liter are shown in Figure 4 (top). At zero bicarbonate concentration the vessels, which were dilated, responded to norepinephrine with a concentration-dependent constriction. However, even at the highest concentration of norepinephrine of 22 mEq/liter, which by itself caused a decrease in vessel diameter of 20!? (Fig. 1) , norepinephrine did not elicit further reductions in diameter. Also included in Figure 4 is the concentration-response curve obtained at a bicarbonate concentration of 11 mEq/liter (also shown in Fig. 2 ). In this curve the reduction in diameter at 2.5 mmoles/liter of norepinephrine exceeded that found at 22 mEq/liter of bicarbonate.
The bottom of Figure 4 depicts the concentration-response curves for norepinephrine alone after the pH effect due to the different bicarbonate content of the solvents (tested at each vessel before application of norepinephrine) has been subtracted from the responses to norepinephrine and solvent shown in the top of Figure 4 . At 22 mEq/liter of bicarbonate, no norepinephrine-induced constriction could be detected at norepinephrine concentrations ranging from 5 X 10~* to 5.0 mmoles/liter. At 0 mEq/liter of bicarbonate, there was a concentration-dependent constriction which was less than the constriction observed at 11 mEq/liter of bicarbonate.
Discussion
METHODS
The microapplication technique used in this study made it possible to apply only a few microliters of test solution to a local segment of one artery or arteriole, and hence secondary effects on vascular resistance caused by changing neuronal activity appear to have been eliminated.
The "pial window" technique used by others (28-30, 37, 38) requires flushing of the whole field of observation with the test solutions and hence catecholamines, particularly at high concentrations, might cause changes in neuronal function with secondary changes in blood flow and vessel diameter.
Another advantage of the microapplication technique was that the reactivity of each pial artery to different bicarbonate-containing solutions could be tested locally before the application of norepinephrine-containing mock spinal fluids. The best approach to test the influence of pH on the norepinephrineinduced effect was to measure concentrationresponse curves for norepinephrine dissolved in solutions of different bicarbonate content on the same vessel. To test if such a repetitive performance of a concentration-response curve altered the vascular reaction, two concentration-response curves for norepinephrine at bicarbonate concentrations of 11 mEq/ liter were taken from each of five vessels. Analysis of variance revealed a significantly lower degree of constriction for the second concentration-response curve. (P<0.01) (range of norepinephrine concentrations 5 X 1(H to 5.0 mmoles/liter). When only one concentration of norepinephrine (5.0 X10-1 mmoles/liter in 11 mEq/liter of bicarbonate) was tested repeatedly (seven times) on the same vessel, the constrictor response was unchanged during the first three applications. Later the response was diminished. For this reason only one concentrationresponse curve was performed for each vessel.
It is apparent that the microapplication technique allowed the construction of concentration-response curves from many vessels not previously exposed to norepinephrine in the same animal. This method presents an obvious advantage compared to the window technique in which all exposed vessels are rinsed with norepinephrine when a concentration-response curve is taken. From our results, one would expect the window technique to give a diminished responsiveness to norepinephrine when more than one concentration-response curve is obtained from the same animal.
The relatively weak constrictor response observed with 5.0 mmoles/liter of norepinephrine in 11 mEq/liter of bicarbonate cannot be explained by a diminished sensitivity of the vessel caused by previous injection of norepinephrine in the course of obtaining the concentration-response curves. This follows from the observation that when only 5.0 mmoles/liter of norepinephrine was applied to vessels previously not exposed to norepinephrine, the same results were obtained.
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RESULTS
The demonstration of a concentration-dependent vasoconstriction of pial arteries by norepinephrine may support the concept of a sympathetic control of cerebral vessels, although it cannot be taken as evidence for such control. Fraser et al. (37) irrigated the subarachnoid space of the basilar and vertebral arteries of monkeys with norepinephrine (2.2 X 10-8 to 2.2 X 10^ g/ml) and observed vasoconstriction. Raper et al. (38) , using the window technique, found no effect of norepinephrine (1 X lO^3 to 2 x 10" 5 g/ml) on pial arteries. This classical technique has also been frequently used to study the effect of epinephrine on pial arteries. Although the technique has some disadvantages (see discussion of methods) most of the results indicate a constrictor effect of epinephrine (28, 29) . In preliminary studies (39) , we have also observed a decrease in vessel diameter when epinephrine was applied by the method described in this report.
The results of local applications of catecholamines are thus in contrast with results obtained with intracarotid administration where no effect could be obtained (5, 6) . Two possibilities may explain the different effect of blood-borne and locally applied norepinephrine. (1) To avoid an increase in arterial blood pressure, only small amounts of norepinephrine can be infused into the carotid artery. It can be calculated that the maximal concentration of norepinephrine in the blood of the internal carotid artery might be in the range of 5 x 1 0^ mmoles/liter (5, 6) . This concentration applied locally resulted in an insignificant decrease in vessel diameter of only 1.855. Thus the effective concentration of norepinephrine at the smooth muscle receptor site resulting from this type of intra-arterial infusion might be too low to initiate a vasoconstriction even if there was no bloodbrain barrier to norepinephrine. (2) The existence of a blood-brain barrier for norepinephrine (40) (41) (42) (43) might prevent intra-arterially infused norepinephrine from reaching the smooth muscle cells. This, however, presumes that the barrier for norepinephrine is bound to the endothelial layer rather than to the glial cells, as has been shown for other substances (44, 45) .
Probably the concentration in the test solutions represents the actual concentration around the vessel under investigation. Assuming this, the cerebral vessels are less sensitive to norepinephrine than are vessels of other organs (46) . For a reduction in vessel diameter of about 1585, 10 times more norepinephrine was needed than at mesenteric vessels and 400 times more than at cremasteric vessels. For a reduction of 40*, 500 and 25,000 times more norepinephrine was needed. If one compares cerebral vascular sensitivity to the sensitivity of the organism as a whole, as judged from the blood pressure response after intravenous injection, it appears that the brain vessels are very insensitive. Thus blood concentrations comparable to the local concentrations in this study would demand injection of between 1-10 mg of norepinephrine, or at least 1,000 times the dose required to produce a clear-cut pressor response in the cat.
Several possibilities exist to explain the high concentrations needed to obtain a constrictor response of the pial arteries. (1) There might be some land of barrier between the site of injection and the smooth muscle receptor site.
(2) A high rate of breakdown of norepinephrine might exist (e.g., a high inactivation rate by monoamine oxidase, catechol-O-methyltransferase, or both). (3) A relatively higher uptake of norepinephrine might be present in pial arteries, which is due to the rich adrenergic innervation. Such a mechanism would allow the uptake of large amounts of exogenously administered norepinephrine into the nerve endings, resulting in a lower effective receptor concentration. Although we have no information to support the first two hypotheses, the data of Trendelenburg et al. (47) might argue in favor of the third one. These authors reported (48) that the medial muscle of the nictitating membrane of the cat "contains about twice the amount of endogenous norepinephrine and takes up about twice the amount of exogenous norepinephrine as does the inferior muscle. On the other hand, the sensitivity of the medial muscle to norepinephrine is significantly lower than that of the inferior muscle. Hence, sensitivity to exogenous norepinephrine might be inversely related to density of innervation."
In the present study, the onset of reduction in vessel diameter occurred within 3-5 seconds after the application of norepinephrine. This short latency of vascular reaction, which supports a direct action on the vascular smooth muscle cell, has also been found by Meyer et al. (13) after stimulation of the cervical ganglia. Further support for a direct vascular action of norepinephrine comes from studies on isolated cerebral vessels, which show constriction at concentrations of norepinephrine similar to those used in this study (49) or at even lower concentrations (50) .
The effect of norepinephrine on vascular diameter was modified by the bicarbonate concentration ( Fig. 4) . At a bicarbonate concentration of 22 mEq/ liter the vessels were insensitive to norepinephrine. The lack of response to norepinephrine is not explained by an auto-oxidation of norepinephrine in alkaline solutions. To test such a possibility, solutions with different bicarbonate and norepinephrine concentrations were prepared. Within 6-8 hours, the longest duration of an experiment, their pressor activities were assayed in five pentolinium-treated rats by measuring the change in blood pressure. The solution containing 0 mEq/liter of bicarbonate retained its original pressor activity during this period, whereas norepinephrine at bicarbonate concentrations of 11 or 22 mEq/liter lost pressor activity corresponding to a decrease in norepinephrine concentration of 4035. Since a wide range of concentrations was tested, this decrease in norepinephrine concentration would only displace the concentration-response curve towards the right without changing its slope. It therefore appears that the biological action of norepinephrine on pial arteries was inhibited in an alkaline milieu. Also in acidic milieu the effect seemed to be partially inhibited, because the slope of the concentration-response curve was less with the solution containing no bicarbonate than it was CtrcuUsio* RiMTcb, Vol. XXXI. A at us I 1972 with the solution containing 11 mEq/liter of bicarbonate. Norepinephrine, therefore, seems to exert its maximal action in a milieu which itself does not influence vessel diameter (Fig.  4) . The result of a reduced effect of norepinephrine in an acidic milieu is in agreement with results obtained with an aortic strip preparation (51) .
The present data demonstrate that the pial arteries are sensitive to norepinephrine acting from the perivascular side. If sympathetic control plays a role in the regulation of cerebral blood flow, the present data indicate that the sympathetically induced vascular tone can be influenced by the local perivascular P H.
